Page last updated: 2024-08-17

quinoxalines and Leishmania Infection

quinoxalines has been researched along with Leishmania Infection in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Ospina-Villa, JD; Soto-Sánchez, J1
Cogo, J; Corrêa, AG; Kaplum, V; Nakamura, CV; Sangi, DP; Ueda-Nakamura, T1

Reviews

1 review(s) available for quinoxalines and Leishmania Infection

ArticleYear
Current status of quinoxaline and quinoxaline 1,4-di-N-oxides derivatives as potential antiparasitic agents.
    Chemical biology & drug design, 2021, Volume: 98, Issue:4

    Topics: Animals; Antiparasitic Agents; Benzene; Chagas Disease; Humans; Leishmaniasis; Malaria; Oxidation-Reduction; Oxides; Pyrazines; Quinoxalines; Structure-Activity Relationship

2021

Other Studies

1 other study(ies) available for quinoxalines and Leishmania Infection

ArticleYear
In Vitro and In Vivo Activities of 2,3-Diarylsubstituted Quinoxaline Derivatives against Leishmania amazonensis.
    Antimicrobial agents and chemotherapy, 2016, Volume: 60, Issue:6

    Topics: Adenosine Triphosphate; Animals; Antiprotozoal Agents; Cell Membrane; Leishmania; Leishmaniasis; Male; Membrane Potential, Mitochondrial; Mice; Mice, Inbred BALB C; Parasitic Sensitivity Tests; Phosphatidylserines; Quinoxalines; Superoxides

2016